baltimorebullet
8 minutes ago
Maybe anything speedy or even timely is a pipe dream.
"FDA leadership noted that Humacyte’s ATEV is a first-in-class product, and that Priority Review had been granted, which allows only a six-month review cycle, as compared to the standard ten-month review cycle for most products. During the